HOME >> Investment

Humanwell purchases an American pharmaceutical company

Source: hubei.gov.cn 06/03/2016 05:06:30

Humanwell Healthcare (Group) Co. Ltd announced on March 30 its intention of whole acquisition of Phar-ma, an American pharmaceutical company, and its affiliated company RE Holdco with 550 million U.S. dollars.

So far, Humanwell has tapped the foreign markets of the United States, Mali, Burkina Faso, Ethiopia, Vietnam etc.

According to data, Pharma was founded in 2008, and was an American pharmaceutical company whose business included the manufacture, development and sale of generic prescription drugs. In 2015, Pharma and RE Holdco realized a turnover of 117 million U.S. dollars with 57.63 million U.S. dollars of net profit.

Brief Introduction to Humanwell:

Founded in 1993, Humanwell Healthcare (Group) Co. has since transformed into a fully integrated healthcare solution provider. Headquartered at the center of China, Humanwell is active in over 10 countries. Over the last two decades, Humanwell has been endeavoring to improve people's health through supplying customers with top quality healthcare services and products.